Physician

David Charles Semler, M.D.

According to 2025 Medicare claims, David Semler, M.D. (NPI: 1063470078) practices dermatology in the Kalamazoo-Portage, MI market, with the plurality of this provider's patient population coming from Kalamazoo, MI. This provider's primary affiliated billing organization is PARAGON HEALTH, P.C. (NPI: 1902847098; TIN: 383309299) and primary practice location at 49024-4883.

Semler's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 654 traditional Medicare patients, billed 3,101 HCPCS/CPT codes, and received $176,756 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 984 prescription claims across 432 beneficiaries totaling $721,056 in drug costs, led by Erivedge (Vismodegib). Open Payments data shows 79 records totaling $1,976. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $398,438 and ending at $176,756. Concurrently, Part D prescription costs have risen steadily, from $385,984 to $721,056. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$199K$398K2015 Medicare payment: $398,438 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $225,395 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $254,259 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $243,670 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $394,507 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $273,608 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $275,655 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $240,192 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $199,773 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $176,756 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,1836,614$398,438
20161,2085,450$225,395
20171,2325,764$254,259
20181,2175,945$243,670
20191,2907,499$394,507
20201,1465,806$273,608
20211,1685,461$275,655
20227964,456$240,192
20236573,474$199,773
20246543,101$176,756

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$449K$898K2015 Drug cost: $385,984 (USD; Tot_Drug_Cst)2016 Drug cost: $461,102 (USD; Tot_Drug_Cst)2017 Drug cost: $442,407 (USD; Tot_Drug_Cst)2018 Drug cost: $541,761 (USD; Tot_Drug_Cst)2019 Drug cost: $486,110 (USD; Tot_Drug_Cst)2020 Drug cost: $526,352 (USD; Tot_Drug_Cst)2021 Drug cost: $746,880 (USD; Tot_Drug_Cst)2022 Drug cost: $603,530 (USD; Tot_Drug_Cst)2023 Drug cost: $898,392 (USD; Tot_Drug_Cst)2024 Drug cost: $721,056 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154731,174$385,984
20165671,504$461,102
20176131,785$442,407
20186191,537$541,761
20196171,704$486,110
20206501,664$526,352
20216591,616$746,880
20224821,094$603,530
2023423993$898,392
2024432984$721,056

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths137148$75
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more278372$59
17000Destruction of precancer skin growth, 1 growth185245$38
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more7680$35
17003Destruction of precancer skin growth, 2-14 growths122696$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ErivedgeVismodegib11318$152,445
OtezlaApremilast30896$140,900
FluorouracilFluorouracil812,552$4,929
Clobetasol PropionateClobetasol Propionate1163,861$3,899
PimecrolimusPimecrolimus14505$3,277

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.79$1,976ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David Charles Semler, M.D.?

Tedicare shows public-source Medicare data for David Charles Semler, M.D. (NPI 1063470078), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Charles Semler, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David Charles Semler, M.D.?

David Charles Semler, M.D. is linked to PARAGON HEALTH, P.C. (billing NPI 1902847098) in the available physician profile data.

Does David Charles Semler, M.D. have Open Payments data?

David Charles Semler, M.D. has 79 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.